US Patent Issued to Tianjin Hemay Pharmaceutical Sci-Tech, Ganzhou Hemay Pharmaceutical on June 17 for "Piperidine-2,6-dione derivatives and ulcerative colitis treating" (Chinese Inventors)

ALEXANDRIA, Va., June 19 -- United States Patent no. 12,331,030, issued on June 17, was assigned to Tianjin Hemay Pharmaceutical Sci-Tech Co. Ltd (Tianjin, China) and Ganzhou Hemay Pharmaceutical Co. Ltd (Ganzhou, China).

"Piperidine-2,6-dione derivatives and ulcerative colitis treating" was invented by Hesheng Zhang (Tianjin, China) and Guanghuai Zeng (Tianjin, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are piperidine-2,6-dione derivatives and treatment of ulcerative colitis."

The patent was filed on Dec. 8, 2023, under Application No. 18/533,755.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITO...